Sponsor:
Kite, A Gilead Company
Code:
NCT04989803
Conditions
Relapsed and/or Refractory B-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cyclophosphamide
Fludarabine
KITE-363
KITE-753
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Kite, A Gilead Company on 2026-06-03.